Printer Friendly

T CELL SCIENCES NAMES ALAN W. TUCK PRESIDENT & CEO

 T CELL SCIENCES NAMES ALAN W. TUCK PRESIDENT & CEO
 CAMBRIDGE, Mass., Feb. 7 /PRNewswire/ -- T Cell Sciences, Inc.


(NASDAQ: TCEL), today announced that Alan W. Tuck has been named president and chief executive officer of T Cell Sciences, Inc. James D. Grant will continue in his capacity as chairman of the board of T Cell Sciences, Inc.
 Tuck, who was vice president, marketing and business development for Biogen, Inc. from 1987 to 1991, brings broad management experience to T Cell Sciences. Prior to joining Biogen, Tuck was a management consultant for Bain & Co. and from 1971 to 1984 he held numerous management positions with Cummins Engine Company. Tuck received his MBA from the Amos Tuck School at Dartmouth in 1971 and a BA from Dartmouth in 1970.
 "I am pleased Alan Tuck has decided to join us. He will make a substantial contribution to the future growth of T Cell Sciences," said James D. Grant, chairman of the board of T Cell Sciences. "His business development expertise and general management experience will greatly strengthen the management team of the company. With the recently completed agreement with AB Astra regarding the joint development, manufacturing and marketing for T cells antigen receptor products and the progression of the first complement blocker product closer to the clinic, T Cell Sciences is about to enter an important new phase in its development and we are looking forward to Alan's leadership in this new period."
 Located in Cambridge, T Cell Sciences, Inc. is utilizing proprietary T cell receptor and soluble receptor technology to develop pharmaceutical products to treat heart disease, inflammatory diseases, autoimmune diseases and cancer. T Cell Diagnostics, Inc. a subsidiary of T Cell Sciences, develops, manufactures, and markets products for monitoring immune system disorders.
 -0- 2/7/92
 /CONTACT: James D. Grant, chairman & CEO, 617-621-1400; or Susan Primrose, 617-621-1400, both of T Cell Sciences/
 (TCEL) CO: T Cell Sciences Inc. ST: Massachusetts IN: MTC SU: PER


SH -- NY011 -- 8056 02/07/92 08:48 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 7, 1992
Words:332
Previous Article:ANDOVER TOGS ANNOUNCES FOURTH QUARTER AND YEAR-END RESULTS
Next Article:HERCULES REPORTS FOURTH-QUARTER NET INCOME UP SUBSTANTIALLY FROM A YEAR AGO
Topics:


Related Articles
T CELL SCIENCES NAMES DAVID W. MITCHELL VP, PHARMACEUTICAL DEVELOPMENT
T CELL SCIENCES NAMES JACQUELINE D. ARTHUR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
T CELL SCIENCES ADDS THOMAS R. OSTERMUELLER TO BOARD OF DIRECTORS
T CELL SCIENCES, INC. PROMOTES JAMES LEVIN, DVM, TO VICE PRESIDENT OF DEVELOPMENT
NORMAN W. GORIN JOINS T CELL SCIENCES, INC. AS VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER
T CELL SCIENCES ANNOUNCES CHANGES IN MANAGEMENT
T CELL SCIENCES ANNOUNCES BOARD RESIGNATION
Dyax Creates Strategic Advisory Committee

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters